Connect
MJA
MJA

Ageing Holocaust survivors in Australia

Elizabeth D Paratz and Benny Katz
Med J Aust 2011; 194 (4): 194-197. || doi: 10.5694/j.1326-5377.2011.tb03771.x
Published online: 21 February 2011

During the 1940s, over 35 000 European Jews immigrated to Australia. Australia has the largest per-capita Holocaust survivor population outside Israel, principally concentrated in Melbourne, Sydney and Brisbane.1 The remaining survivors are now over 65 years of age.

“Early effects of the Holocaust” were well delineated in scientific articles in the 1950s as “concentration camp syndrome”, mainly comprising severe post-traumatic stress disorder (PTSD) and consequent poor functioning in postwar society.2 In recent years, a phenomenon of “late effects of the Holocaust” has emerged, with impacts on the psychological and physical health of some ageing Holocaust survivors. These late effects have been reported in several countries with large Holocaust survivor populations, including Australia, the United States, Canada and Israel.1,3-5

Although some of the late problems experienced by Jewish Holocaust survivors are unique, others are common to other groups who have survived severe physical and psychological trauma such as Australian prisoners of war (POWs) on the Burma Railway or in the Changi Prison camp,6,7 and more recent waves of immigrants to Australia from, for example, Vietnam, Cambodia, Bosnia and Sudan.8

We examined the late effects of the Holocaust using keywords elderly AND Holocaust AND survivors and related synonyms. Relevant articles in English that were published from 1990 to August 2010 were identified through database searches (MEDLINE) and citation tracking. Seventeen studies were relevant, which were primarily from Australia, the US, Canada and Israel.

Psychological and cognitive problems
Coping with ageing and comorbidities

The harsh environment of the Holocaust had dramatic psychosocial effects on many survivors’ concepts of health, creating an ingrained belief that perfect physical health was necessary to survive.9 Consequently, some survivors experience disproportionate anxiety when informed that they require standard non-invasive geriatric aids such as walking sticks, dentures, glasses and hearing aids. The idea that they are becoming weaker may be challenging to their self-image as “the ultimate survivor”.10

Several studies have found that Holocaust survivors cope much worse than controls with diagnoses of disease. A retrospective analysis of 106 patients matched for sociodemographic and medical background showed that survivors diagnosed with cancer exhibit disproportionate psychological distress, are less able to mobilise partial denial and score higher on avoidance and intrusiveness, culminating in worsened psychosocial outcomes.11 One limitation of this study was a lack of data on participants’ premorbid psychological function.

In a comparative study of 66 survivors and controls with chronic pain, survivors reported higher pain levels, more pain sites and significantly higher depression scores.12 Weight loss may be a particularly emotionally invested symptom due to Holocaust memories of emaciation and death by starvation. Likewise, swallowing problems and other causes of dysphagia may provoke fear and distress.

The onset of a decline in coping and psychological distress in old age may erode the will to live. Recent publications have found that older Holocaust survivors with depression are 52% more likely to report suicidal ideation and 2.9 times more likely to attempt suicide than controls with depression.3,4

Worsening of post-traumatic stress disorder symptoms with cognitive decline

Among the Australian Holocaust survivor population, the prevalence of PTSD is estimated at 39%.1 Previously identified risk factors for worsened PTSD symptoms among Australian Holocaust survivors include increased age, severity of trauma, use of immature defence mechanisms, and higher neuroticism.13

Dementia is present among 22.4% of people aged 85 years and over.14 Furthermore, Holocaust survivors may be at an elevated risk of vascular dementia owing to an unfavourable cardiometabolic profile (see below).15 Thus, the impact of cognitive decline on Holocaust survivors may be profound on an individual and community level.

With cognitive decline, PTSD severity may worsen as repressed memories in the brain are liberated. Previously high-functioning patients may become “uncontrollable and highly disruptive following the onset of neurologic illness”.5 It is conjectured that cognitive decline “diminishes patients’ capacity to inhibit intrusive traumatic memories . . . resulting in a re-emergence of PTSD symptoms accompanied by intense feelings of anxiety and depression”.5

The sequelae of this phenomenon may be profound. When recalling their experiences, survivors are confronted once more with memories of the deaths of loved ones, and torture at the hands of guards and doctors. They may lose their connection to the family they have created in Australia, and to memories of their post-war success and stability. As dementia progresses, acquired language skills in English may be lost, rendering them less able to communicate with family and medical staff.5

Even for those who do not develop dementia, the life-cycle changes of ageing can still precipitate worsening of PTSD severity. Prototypical stressors of ageing, such as retirement, the loss of a spouse or close friends, health problems and an increased awareness that, once again, death is close, may all drive worsened functioning and increased reporting of PTSD symptoms.2 Similar findings have been noted in participants who were Australian POWs in the Changi Prison camp or on the Burma Railway during World War II.6,7

Fear of the medical system

A Sydney researcher elaborated the reasons underlying survivors’ understandable distrust and fear of the medical profession —

There are many traumatic cues in the medical experience for Holocaust survivors; even calling an ambulance may be psychologically overwhelming. In the 1990s, Melbourne’s Metropolitan Ambulance Service recorded an inappropriately low number of call-outs for chest pain from the suburbs in Melbourne with the highest proportion of Holocaust survivors. It was thought that survivors apparently preferred transport by family members, at the expense of “door-to-needle time”.16

Hospitalisation is a great upheaval commonly experienced by survivors. Traumatic cues include “absence of family members, loss of privacy, increased sense of vulnerability, and invasion of the body by medical examinations”.17 Survivors frequently develop delusions of being in the camps again.10 This may result in an apparently inexplicable extreme fear of medical staff, due to misinterpretation of their actions and motives (Box 1).

Direct medical complications of the Holocaust

An Israeli study of 86 survivors found that 60% of survivors suffered from direct medical legacies of their Holocaust experience.18 As distribution of Holocaust survivors to new countries was not linked to age, health status or nature of Holocaust experiences, the Australian cohort would presumably be comparable in this regard. Across all diseases, prevalence and severity was greatest in the youngest survivors (ie, under 17 years old in 1945), who presumably bore the greatest physiological stress to their development.19

Hypothalamic–pituitary–adrenal axis dysfunction and raised cardiometabolic risk

Exposure to extreme physiological stress during critical periods of development may trigger permanent changes in cardiometabolic, neurological and endocrine function (the “Barker hypothesis”).15 Investigation of cortisol levels among Holocaust survivors has revealed that they showed adaptive programming, with reduced cortisol metabolism via renal 11β-hydroxysteroid dehydrogenase-2 and hepatic 5α-reductase and enhanced tissue responsiveness to corticosteroids.15 Although this modulation in the hypothalamic–pituitary–adrenal axis would have been beneficial during acute starvation and salt depletion, in the longer term it places Holocaust survivors at increased risk of cardiometabolic disease, such as hypertension, diabetes, atherosclerotic heart disease, dyslipidaemia, and vascular dementia. Limitations of this study, however, included reliance on medical chart review for diagnosis of current cardiovascular disease, lack of detail on method of participant recruitment, and imperfect matching of the control population for sex.

Sequelae of Nazi medical experiments

Doctors in the death camps performed unethical experiments on large numbers of prisoners.22,23 Procedures included incompatible unsterile blood transfusions, injections of toxic substances, and unanaesthetised operations, including abortions and male and female sterilisations.23-26 The effects of these experiments may create late sequelae and new problems decades after the Holocaust. One case study reported that a patient subjected to left intra-testicular injection with an unknown substance in Auschwitz in 1943 developed a secondary giant malignant fibrous histiocytoma of the testis and spermatic cord 53 years later.27

Optimising treatment of Holocaust survivors

Holocaust survivors are a distinct older patient population with unique and identifiable needs evident in the scientific literature. They may react to the physiological changes of ageing with distress and fear, cope poorly with chronic medical conditions, and experience re-traumatisation and worsening of posttraumatic stress with the onset of cognitive decline. In addition, there are discernible direct medical sequelae of the Holocaust experience that need to be recognised and investigated by medical staff.

Despite the need for increased medical support and follow-up for Holocaust survivors, this population has a learned fear of the medical system. However, there are steps that health professionals can take to optimise medical management of Holocaust survivors.

The first step is education and raising awareness. The difficulty of caring for older Holocaust survivors is under-acknowledged within the medical system. Survivors may be dismissed as “problem patients”, without recognition of the wider trends within this demographic. Increasing research will enable health professionals to draw on a greater database of solutions to common scenarios.

In dealing with Holocaust survivor patients on an individual basis, there are several points that may help optimise rapport and outcomes (Box 2). History-taking is crucial, and obviously recognising a patient as a Holocaust survivor is essential. Unfortunately, history of Holocaust survival is frequently neglected by doctors. One Israeli study showed that 15% of long-term psychiatric patients were unrecognised Holocaust survivors.28 An American study corroborated this trend, revealing that the charts of 33% of Holocaust survivors bore no mention of their experiences.29 Clues to Holocaust survival may be as subtle as age, Jewish name, religion, European birthplace or accent, or as obvious as a number tattooed on the left forearm (Box 3).

If a patient is comfortable with discussing their Holocaust experiences, it is desirable to sensitively elicit a detailed history of experiences, particularly focusing on issues with relevance to current health; for example, psychological health, degree of malnutrition and long-term complications of medical experimentation.

If a survivor is admitted to hospital, subsequent medical management should minimise traumatic cues and maximise the patient’s sense of autonomy insofar as possible. Ethnospecific services (Box 4) may also be of great help in coordinating ongoing local care.

Although this article specifically addresses the late effects of the Holocaust, many of the complexities in medical management are broadly applicable to the general refugee experience. The principles of sensitive medical care outlined here may thus be useful in approaching the care of elderly refugees from other ethnic backgrounds, for example, Cambodian, Bosnian or Sudanese refugees, as well as older Australian veterans.30 Apart from the common generic issues, each community will also have their own unique cultural issues requiring elucidation for best medical management.

Conclusion

Late life is often a time of increased health vulnerability. Holocaust survivors are particularly susceptible to adverse psychological and medical outcomes resulting from their experiences earlier in life. This may also affect the doctor–patient relationship, secondary to their underlying distrust of medical professionals. Awareness, sensitive history taking and careful multidisciplinary management are key to improving survivors’ health and trust in medical personnel.

Australia is a country characterised by large refugee minority groups, and experiences with Holocaust survivors should be recalled when dealing with subsequent waves of refugees who have come to Australia and older Australian veterans.

  • Elizabeth D Paratz1,2
  • Benny Katz2,3,4

  • 1 University of Melbourne, Melbourne, VIC.
  • 2 St Vincent’s Health, Melbourne, VIC.
  • 3 Victorian Geriatric Medicine Training Program, Melbourne, VIC.
  • 4 Australian Centre for Evidence Based Aged Care, La Trobe University, Melbourne, VIC.


Correspondence: EParatz@hotmail.com

Competing interests:

None identified.

  • 1. Joffe C, Brodaty H, Luscombe G, et al. The Sydney Holocaust study: posttraumatic stress disorder and other psychosocial morbidity in an aged community sample. J Trauma Stress 2003; 16: 39-47.
  • 2. Landau R, Litwin H. The effects of extreme early stress in very old age. J Trauma Stress 2000; 13: 473-487.
  • 3. Clarke DE, Colantonio A, Heslegrave R, et al. Holocaust experience and suicidal ideation in high-risk adults. Am J Geriatr Psychiatry 2004; 12: 65-74.
  • 4. Barak Y. The aging of Holocaust survivors: myth and reality concerning suicide. Isr Med Assoc J 2007; 9: 196-198.
  • 5. Grossman AB, Levin BE, Katzen HL, et al. PTSD symptoms and onset of neurological disease in elderly trauma survivors. J Clin Exp Neuropsychol 2004; 26: 698-705.
  • 6. Watson IP. Post-traumatic stress disorder in Australian prisoners of the Japanese: a clinical study. Aust N Z J Psychiatry 1993; 27: 20-29.
  • 7. Neal LA, Hill N, Hughes J, et al. Convergent validity of measures of PTSD in an elderly population of former prisoners of war. Int J Geriatr Psychiatry 1995; 10: 617-622.
  • 8. Kinzie JD, Frederickson RH, Ben R, et al. Post-traumatic stress disorder among survivors of Cambodian concentration camps. Am J Psychiatry 1984; 141: 645-650.
  • 9. Rosenbloom M. Lessons of the Holocaust for mental health practice. In: Braham RL, editor. Psychological perspectives of the Holocaust and its aftermath. New York: Columbia University Press, 1988: 145-159.
  • 10. Ehrlich MA. Health professionals, Jewish religion and community structure in the service of the aging Holocaust survivor. Arch Gerontol Geriatr 2004; 38: 289-295.
  • 11. Baider L, Peretz T, Kaplan De-Nour A. Effect of the Holocaust on coping with cancer. Soc Sci Med 1992; 34: 11-15.
  • 12. Yaari A, Eisenberg E, Adler R, et al. Chronic pain in Holocaust survivors. J Pain Symptom Manage 1999; 17: 181-187.
  • 13. Brodaty H, Joffe C, Luscombe G, et al. Vulnerability to post-traumatic stress disorder and psychological morbidity in aged Holocaust survivors. Int J Geriatr Psychiatry 2004; 19: 968-979.
  • 14. Australian Institute of Health and Welfare. Dementia in Australia: national data analysis and development. Canberra: AIHW, 2006. (AIHW Cat. No. AGE 53) http://www.aihw.gov.au/publications/age/dandad/dandad.pdf (accessed Aug 2010).
  • 15. Yehuda R, Bierer LM, Andrew R, et al. Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors. J Psychiatr Res 2009; 43: 877-883.
  • 16. Chan T, Braitberg G, Elbaum D, Taylor DM. Hatzolah emergency medical responder service: to save a life. Med J Aust 2007; 186: 639-642. <MJA full text>
  • 17. Schreiber S, Soskolne V, Kozohovitch H, et al. Holocaust survivors coping with open-heart surgery decades later: post-traumatic symptoms and quality of life. Gen Hosp Psychiatry 2004; 26: 443-452.
  • 18. Robinson S, Rapaport J, Durst R. The late effects of Nazi persecution among elderly Holocaust survivors. Acta Psychiatr Scand 1990; 82: 311-315.
  • 19. Marcus EL, Menczel J. Higher prevalence of osteoporosis among female Holocaust survivors. Osteoporos Int 2007; 18: 1501-1506.
  • 20. Hursting SD, Forman MR. Cancer risk from extreme stressors: lessons from European Jewish survivors of World War II. J Natl Cancer Inst 2009; 101: 1436-1437.
  • 21. Keinan-Boker L, Vin-Raviv N, Lipshitz I, et al. Cancer incidence in Israeli Jewish survivors of World War II. J Natl Cancer Inst 2009; 101: 1489-1500.
  • 22. Mellanby K. Medical experiments on human beings in concentration camps in Nazi Germany. BMJ 1947; 1: 148-150.
  • 23. Wiesel E. Without conscience. N Engl J Med 2005; 352: 1511-1513.
  • 24. Benedict S, Georges JM. Nurses and the sterilization experiments of Auschwitz: a post-modernist perspective. Nurs Inq 2006; 13: 277-288.
  • 25. Muller-Hill B. Genetics of susceptibility to tuberculosis: Mengele’s experiments in Auschwitz. Nat Rev Genet 2001; 2: 631-634.
  • 26. Bachrach S. In the name of public health: Nazi racial hygiene. N Engl J Med 2004; 351: 417-421.
  • 27. Staiman VR, O’Toole KM, Rubin MA, et al. Giant malignant fibrous histiocytoma of the testis/spermatic cord: psychologic and possible etiologic complications of unethical Nazi medical experimentation. Urology 1996; 48: 939-943.
  • 28. Kremer I. The long-term effects of the trauma of the Holocaust. Isr J Psychiatry Relat Sci 2008; 45: 227-229.
  • 29. Axelrod S, Schnipper OL, Rau JH. Hospitalized offspring of Holocaust survivors: problems and dynamics. Bull Menninger Clin 1980; 44: 1-14.
  • 30. Momartin S, Silove D, Manicavasagar V, Steel Z. Comorbidity of PTSD and depression: associations with trauma exposure, symptom severity and functional impairment in Bosnian refugees resettled in Australia. J Affect Disord 2004; 80: 231-238.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.